The Krka Group is an innovative generic pharmaceutical company. Its core business is the production and sale of prescription drugs, which account for over 80% of revenues. The remaining portfolio consists of non-prescription medicines and veterinary products. The company conducts its own research and development, manufacturing active ingredients and finished products. Production takes place in facilities in Slovenia, Russia, Poland, Croatia and Germany. The Group has an extensive sales and marketing network in over 70 countries. The main markets are Eastern Europe, Central Europe and Western Europe. Krka is listed on the Ljubljana and Warsaw stock exchanges.
